CN/EN

Search
Hotline:86-512-62697697

About Us

Hotline:
86-512-62697697
Add.:
Room 303 & 305, Building 15, Suzhou Medpark, No. 8 Jingfeng Road, Suzhou New District
HomeAbout Us : Letter from Manager of Bright ScistarLetter from Manager of Bright Scistar
Dear friends,
I would like to extend our warmest greetings from all staff at Suzhou Bright Scistar Biotechnology Company.

Bright Scistar was established in 2013. It is a key science and technology institute of Suzhou New District. Our company works on the research and development, production and marketing of costimulatory molecules, an important target in immunologic diagnosis and treatment, and relative biologics. Our products include a series of antibodies, reagent kits, IVD Reagents and antibody medicine for treatment.

Bright Scistar gathered a group of technology advisors who has great influence in the field of immunology, and formed a research team. Based on achievements and experience of more than 30 years by leading figure Professor Zhang Xueguang, we integrated immense academic resource and clinical experiences, and established a cooperative laboratory of antibody engineering with Soochow University at 2014. Bright Scistar has the biggest purification lab and field for research, development and production in the region. We also have built a public technology platform with Jiangsu Medpark and Suzhou New Medicine Innovation and Production Center, and applied to establish Jiangsu Provincial Public Service and Test Platform of Antibody Engineering cooperatively, in order to offer laboratory service and relative technical support for regional industry partners. It is distinctively advantages and experimental that our company has developed a series of monoclonal antibodies that antagonize costimulatory molecules. We hold it as our goal to establish a hatching system for technology innovation by basing on the company, aiming at the market, and combining production, academics and reseaches.

Basing on the cooperation of Soochow University-Bright Scistar Antibody Engineering Joint Laboratory and Suzhou Biomedical Research and Development Center, our company choses antibody engineering platform as a carrier, forms an open platform of cell bank, antibody and research and production of relative reagents, antibody production and purification, and relative cell/molecule biotechnology, and mobilize regional industry development. It is our aim to offer all-sided anti-body products and relative laboratory services.
General Manager: Hao Xiaomin